Cargando…

IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry

To replicate, viruses must gain access to the host cell's resources. Interferon (IFN) regulates the actions of a large complement of interferon effector genes (IEGs) that prevent viral replication. The interferon inducible transmembrane protein family members, IFITM1, 2 and 3, are IEGs required...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feeley, Eric M., Sims, Jennifer S., John, Sinu P., Chin, Christopher R., Pertel, Thomas, Chen, Li-Mei, Gaiha, Gaurav D., Ryan, Bethany J., Donis, Ruben O., Elledge, Stephen J., Brass, Abraham L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203188/ https://www.ncbi.nlm.nih.gov/pubmed/22046135 http://dx.doi.org/10.1371/journal.ppat.1002337

Ejemplares similares

IFITM3 restricts the morbidity and mortality associated with influenza
por: Everitt, Aaron R., et al.
Publicado: (2012)

Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction
por: Lin, Tsai-Yu, et al.
Publicado: (2013)

IFITMs Restrict the Replication of Multiple Pathogenic Viruses
por: Perreira, Jill M., et al.
Publicado: (2013)

IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion
por: Desai, Tanay M., et al.
Publicado: (2014)

Comprehensive Identification of Host Modulators of HIV-1 Replication using Multiple Orthologous RNAi Reagents
por: Zhu, Jian, et al.
Publicado: (2014)

Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
por: Huang, I-Chueh, et al.
Publicado: (2011)

IFITM proteins — cellular inhibitors of viral entry
por: Smith, SE, et al.
Publicado: (2014)

Ifitm3 Limits the Severity of Acute Influenza in Mice
por: Bailey, Charles C., et al.
Publicado: (2012)

IFITM1 is a tight junction protein that inhibits hepatitis C virus entry,
por: Wilkins, Courtney, et al.
Publicado: (2013)

The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry
por: Amini-Bavil-Olyaee, Samad, et al.
Publicado: (2013)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

IFITM3 and severe influenza virus infection. No evidence of genetic association
por: López-Rodríguez, M., et al.
Publicado: (2016)

IFITM3: How genetics influence influenza infection demographically
por: Wellington, Dannielle, et al.
Publicado: (2019)

Evidence for Paralichthys olivaceus IFITM1 antiviral effect by impeding viral entry into target cells
por: Zhu, Rong, et al.
Publicado: (2013)

Cholesterol determines the cytosolic entry and seeded aggregation of tau
por: Tuck, Benjamin J., et al.
Publicado: (2022)

Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity
por: Stott-Marshall, Robert J., et al.
Publicado: (2022)

IFITM3 affects the level of antibody response after influenza vaccination
por: Lei, Na, et al.
Publicado: (2020)

An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein
por: Yoon, Aerin, et al.
Publicado: (2015)

The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex
por: Ratts, Ryan, et al.
Publicado: (2003)

Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19
por: Regino-Zamarripa, Nora E., et al.
Publicado: (2022)

IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
por: Wrensch, Florian, et al.
Publicado: (2014)

Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
por: Winkler, Michael, et al.
Publicado: (2019)

Comparative analysis of the chicken IFITM locus by targeted genome sequencing reveals evolution of the locus and positive selection in IFITM1 and IFITM3
por: Bassano, Irene, et al.
Publicado: (2019)

Alphavirus Restriction by IFITM Proteins
por: Weston, Stuart, et al.
Publicado: (2016)

IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
por: Melvin, William J., et al.
Publicado: (2015)

IFITM3 Polymorphism rs12252-C Restricts Influenza A Viruses
por: Williams, David Evan Joseph, et al.
Publicado: (2014)

IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization
por: Lanz, Caroline, et al.
Publicado: (2021)

Expression profile and histological distribution of IFITM1 and IFITM3 during H9N2 avian influenza virus infection in BALB/c mice
por: Yu, Meng, et al.
Publicado: (2014)

IFITM Proteins Restrict Viral Membrane Hemifusion
por: Li, Kun, et al.
Publicado: (2013)

Fuse me IFITM can!
por: Fassati, Ariberto
Publicado: (2014)

A novel probe to assess cytosolic entry of exogenous proteins
por: Lu, Qiao, et al.
Publicado: (2018)

The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis
por: Gómez-Herranz, Maria, et al.
Publicado: (2019)

NP and NS1 proteins of H5N1 virus significantly upregulated IFITM1, IFITM2, and IFITM3 in A549 cells
por: Wang, Haifeng, et al.
Publicado: (2019)

Grouper interferon-induced transmembrane protein 3 (IFITM3) inhibits the infectivity of iridovirus and nodavirus by restricting viral entry
por: Zhang, Ya, et al.
Publicado: (2020)

Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells
por: Liu, Bao-Yan, et al.
Publicado: (2017)

Multiple mutations of IFITM3 are associated with COVID-19 susceptibilityregulation function of IFITM3 in COVID-19
por: Guo, Hongzhe, et al.
Publicado: (2023)

Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA(2) subunit
por: Xu, Wang, et al.
Publicado: (2022)

Antiviral Protection by IFITM3 In Vivo
por: Zani, Ashley, et al.
Publicado: (2018)

The IFITM protein family in adaptive immunity
por: Yánez, Diana C., et al.
Publicado: (2019)

Malignancy and IFITM3: Friend or Foe?
por: Rajapaksa, Ushani S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uuq70pf1pbnaij693qeq45rtc9